{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T03:16:33Z","timestamp":1766718993252,"version":"3.48.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,25]]},"DOI":"10.7759\/cureus.100086","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:32:47Z","timestamp":1766716367000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Peritoneal Carcinomatosis Scoring Methods to Assess Resectability in Ovarian Carcinoma"],"prefix":"10.7759","author":[{"given":"Joju Antony","family":"Sebastian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhoshkumar","family":"Bandegudda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalla B","family":"Muralidhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal A","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011, 61:69-90. 10.3322\/caac.20107","journal-title":"CA Cancer J Clin"},{"key":"ref2","unstructured":"International Agency for Research on Cancer. GLOBOCAN 2022. (2022). https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/356-india-fact-sheet.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell DD","year":"2015","unstructured":"Bowtell DD, B\u00f6hm S, Ahmed AA, et al.. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015, 15:668-79. 10.1038\/nrc4019","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan R","year":"2006","unstructured":"Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006, 20:207-25. 10.1016\/j.bpobgyn.2005.10.007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32835f2264","article-title":"Precursors and pathogenesis of ovarian carcinoma","volume":"45","author":"Lim D","year":"2013","unstructured":"Lim D, Oliva E. Precursors and pathogenesis of ovarian carcinoma. Pathology. 2013, 45:229-42. 10.1097\/PAT.0b013e32835f2264","journal-title":"Pathology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.06.048","article-title":"Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: discovery and validation studies","volume":"10","author":"Hellner K","year":"2016","unstructured":"Hellner K, Miranda F, Fotso Chedom D, et al.. Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: discovery and validation studies. EBioMedicine. 2016, 10:137-49. 10.1016\/j.ebiom.2016.06.048","journal-title":"EBioMedicine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520300065039","article-title":"Ovarian cancer\u2014screening, treatment, and follow-up","volume":"273","author":"Seltzer V","year":"1995","unstructured":"Seltzer V, Drukker BH, Gillespie BW, et al.. Ovarian cancer\u2014screening, treatment, and follow-up. JAMA. 1995, 273:491-7. 10.1001\/jama.1995.03520300065039","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2019.03.017","article-title":"Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology","volume":"48","author":"Lavoue V","year":"2019","unstructured":"Lavoue V, Huchon C, Akladios C, et al.. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology. J Gynecol Obstet Hum Reprod. 2019, 48:369-78. 10.1016\/j.jogoh.2019.03.017","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21482","article-title":"The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer","volume":"101","author":"Weinberg LE","year":"2010","unstructured":"Weinberg LE, Rodriguez G, Hurteau JA. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer. J Surg Oncol. 2010, 101:334-43. 10.1002\/jso.21482","journal-title":"J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote I","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, et al.. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010, 363:943-53. 10.1056\/NEJMoa0908806","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe S","year":"2015","unstructured":"Kehoe S, Hook J, Nankivell M, et al.. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet. 2015, 386:249-57. 10.1016\/S0140-6736(14)62223-6","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study","volume":"13","author":"Fagotti A","year":"2006","unstructured":"Fagotti A, Ferrandina G, Fanfani F, Ercoli A, Lorusso D, Rossi M, Scambia G. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol. 2006, 13:1156-61. 10.1245\/ASO.2006.08.021","journal-title":"Ann Surg Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow RE","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002, 20:1248-59. 10.1200\/JCO.2002.20.5.1248","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)","volume":"115","author":"du Bois A","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer. 2009, 115:1234-44. 10.1002\/cncr.24149","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199502000-00002","article-title":"Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"221","author":"Sugarbaker PH","year":"1995","unstructured":"Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995, 221:124-32. 10.1097\/00000658-199502000-00002","journal-title":"Ann Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet P","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996, 82:359-74. 10.1007\/978-1-4613-1247-5_23","journal-title":"Cancer Treat Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1339-0","article-title":"Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index","volume":"16","author":"Llueca A","year":"2018","unstructured":"Llueca A, Serra A, Rivadulla I, Gomez L, Escrig J. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol. 2018, 16:37. 10.1186\/s12957-018-1339-0","journal-title":"World J Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2018-000066","article-title":"Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography","volume":"29","author":"Alc\u00e1zar JL","year":"2019","unstructured":"Alc\u00e1zar JL, Caparros M, Arraiza M, M\u00ednguez J\u00c1, Guerriero S, Chiva L, Jurado M. Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography. Int J Gynecol Cancer. 2019, 29:227-33. 10.1136\/ijgc-2018-000066","journal-title":"Int J Gynecol Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.15406\/ijrrt.2017.04.00092","article-title":"The efficiency of CT at preoperative evaluation stage of PCI in patients with recurrent ovarian cancer","volume":"4","author":"Hural O","year":"2017","unstructured":"Hural O, Mylyan Y, Fetsych M, Yarema R. The efficiency of CT at preoperative evaluation stage of PCI in patients with recurrent ovarian cancer. Int J Radiol Radiat Ther. 2017, 4:349-52. 10.15406\/ijrrt.2017.04.00092","journal-title":"Int J Radiol Radiat Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.08.013","article-title":"Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer","volume":"40","author":"Cascales Campos P","year":"2014","unstructured":"Cascales Campos P, Gil J, Parrilla P. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer. Eur J Surg Oncol. 2014, 40:970-5. 10.1016\/j.ejso.2013.08.013","journal-title":"Eur J Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid BM","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017, 14:9-32. 10.20892\/j.issn.2095-3941.2016.0084","journal-title":"Cancer Biol Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-5939-3","article-title":"Meyers' Dynamic Radiology of the Abdomen: Normal and Pathologic Anatomy","author":"Meyers MA","year":"2011","unstructured":"Meyers MA, Charnsangavej C, Oliphant M. Meyers' Dynamic Radiology of the Abdomen: Normal and Pathologic Anatomy. Springer, NY; 2011. 10.1007\/978-1-4419-5939-3"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1317368","article-title":"Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay","volume":"33","author":"Sugarbaker PH","year":"2017","unstructured":"Sugarbaker PH, Sardi A, Brown G, Dromain C, Rousset P, Jelinek JS. Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay. Int J Hyperthermia. 2017, 33:497-504. 10.1080\/02656736.2017.1317368","journal-title":"Int J Hyperthermia"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-016-0682-x","article-title":"Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis","volume":"122","author":"Laghi A","year":"2017","unstructured":"Laghi A, Bellini D, Rengo M, et al.. Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. Radiol Med. 2017, 122:1-15. 10.1007\/s11547-016-0682-x","journal-title":"Radiol Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5114\/pjr.2018.80247","article-title":"Computed tomography imaging of ovarian peritoneal carcinomatosis: a pictorial review","volume":"83","author":"Sureka B","year":"2018","unstructured":"Sureka B, Meena V, Garg P, Yadav T, Khera PS. Computed tomography imaging of ovarian peritoneal carcinomatosis: a pictorial review. Pol J Radiol. 2018, 83:e500-9. 10.5114\/pjr.2018.80247","journal-title":"Pol J Radiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-019-00914-9","article-title":"Accuracy of CT scan in predicting the surgical PCI in patients undergoing cytoreductive surgery with\/without HIPEC\u2014a prospective single institution study","volume":"10","author":"Goswami G","year":"2019","unstructured":"Goswami G, Kammar P, Mangal R, Shaikh S, Patel MD, Bhatt A. Accuracy of CT scan in predicting the surgical PCI in patients undergoing cytoreductive surgery with\/without HIPEC\u2014a prospective single institution study. Indian J Surg Oncol. 2019, 10:296-302. 10.1007\/s13193-019-00914-9","journal-title":"Indian J Surg Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_306_17","article-title":"Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: a prospective validation study","volume":"54","author":"Tomar TS","year":"2017","unstructured":"Tomar TS, Nair RP, Sambasivan S, Krishna KM, Mathew A, Ahmed IM. Role of laparoscopy in predicting surgical outcomes in patients undergoing interval cytoreduction surgery for advanced ovarian carcinoma: a prospective validation study. Indian J Cancer. 2017, 54:550-5. 10.4103\/ijc.IJC_306_17","journal-title":"Indian J Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2232011081","article-title":"Peritoneal metastases: detection with spiral CT in patients with ovarian cancer","volume":"223","author":"Coakley FV","year":"2002","unstructured":"Coakley FV, Choi PH, Gougoutas CA, et al.. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002, 223:495-9. 10.1148\/radiol.2232011081","journal-title":"Radiology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi DS","year":"2004","unstructured":"Chi DS, Franklin CC, Levine DA, et al.. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol. 2004, 94:650-4. 10.1016\/j.ygyno.2004.01.029","journal-title":"Gynecol Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5704-3","article-title":"Neoadjuvant chemotherapy increases R0 cytoreduction rate but does not improve final outcome in advanced epithelial ovarian cancer","volume":"24","author":"Medina-Franco H","year":"2017","unstructured":"Medina-Franco H, Cort\u00e9s-Gonz\u00e1lez R, Lambreton-Hinojosa F, Fimbres-Morales A, Vargas-Siordia JC. Neoadjuvant chemotherapy increases R0 cytoreduction rate but does not improve final outcome in advanced epithelial ovarian cancer. Ann Surg Oncol. 2017, 24:1330-5. 10.1245\/s10434-016-5704-3","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429581-comparison-of-peritoneal-carcinomatosis-scoring-methods-to-assess-resectability-in-ovarian-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T02:32:48Z","timestamp":1766716368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429581-comparison-of-peritoneal-carcinomatosis-scoring-methods-to-assess-resectability-in-ovarian-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.100086","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}